Maccura Biotechnology Co.Ltd (SHE:300463)
China
· Delayed Price · Currency is CNY 10.59
+0.16 (1.53%)
Apr 29, 2026, 3:04 PM CST
SHE:300463 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Market Capitalization | 6,307 | 6,766 | 8,010 | 9,230 | 10,596 | 16,243 | Upgrade
|
| Market Cap Growth | -20.24% | -15.53% | -13.22% | -12.89% | -34.77% | -37.43% | Upgrade
|
| Enterprise Value | 6,649 | 7,109 | 7,896 | 9,092 | 10,210 | 17,255 | Upgrade
|
| Last Close Price | 10.43 | 11.19 | 13.08 | 14.73 | 16.57 | 27.28 | Upgrade
|
| PE Ratio | - | - | 63.17 | 29.53 | 14.96 | 16.98 | Upgrade
|
| Forward PE | 17.98 | 24.87 | 16.54 | 17.39 | 12.45 | 14.61 | Upgrade
|
| PS Ratio | 2.85 | 3.12 | 3.14 | 3.19 | 2.94 | 4.08 | Upgrade
|
| PB Ratio | 0.99 | 1.07 | 1.25 | 1.40 | 1.62 | 3.58 | Upgrade
|
| P/TBV Ratio | 1.07 | 1.16 | 1.35 | 1.55 | 1.80 | 3.98 | Upgrade
|
| P/FCF Ratio | - | - | - | 391.01 | - | 16.01 | Upgrade
|
| P/OCF Ratio | 13.98 | 11.23 | 12.64 | 10.24 | 12.57 | 10.05 | Upgrade
|
| EV/Sales Ratio | 3.01 | 3.28 | 3.10 | 3.14 | 2.83 | 4.34 | Upgrade
|
| EV/EBITDA Ratio | 18.55 | 17.26 | 13.57 | 14.51 | 9.56 | 11.80 | Upgrade
|
| EV/EBIT Ratio | - | 129.83 | 30.12 | 27.42 | 12.52 | 13.91 | Upgrade
|
| EV/FCF Ratio | -21.56 | - | - | 385.18 | - | 17.00 | Upgrade
|
| Debt / Equity Ratio | 0.15 | 0.15 | 0.10 | 0.10 | 0.11 | 0.25 | Upgrade
|
| Debt / EBITDA Ratio | 2.52 | 2.29 | 1.10 | 1.03 | 0.65 | 0.76 | Upgrade
|
| Debt / FCF Ratio | - | - | - | 28.18 | - | 1.10 | Upgrade
|
| Net Debt / Equity Ratio | 0.03 | 0.04 | -0.01 | -0.07 | -0.08 | 0.11 | Upgrade
|
| Net Debt / EBITDA Ratio | 0.54 | 0.56 | -0.13 | -0.77 | -0.51 | 0.33 | Upgrade
|
| Net Debt / FCF Ratio | -34.15 | -1.56 | 0.23 | -20.42 | 3.81 | 0.47 | Upgrade
|
| Asset Turnover | 0.27 | 0.27 | 0.32 | 0.36 | 0.49 | 0.62 | Upgrade
|
| Inventory Turnover | 0.93 | 1.02 | 1.30 | 1.42 | 1.62 | 1.62 | Upgrade
|
| Quick Ratio | 1.92 | 1.88 | 1.96 | 2.69 | 3.14 | 1.97 | Upgrade
|
| Current Ratio | 3.16 | 3.06 | 3.04 | 3.77 | 4.34 | 2.94 | Upgrade
|
| Return on Equity (ROE) | -0.95% | -0.65% | 1.82% | 4.64% | 12.68% | 23.45% | Upgrade
|
| Return on Assets (ROA) | 0.15% | 0.43% | 2.04% | 2.54% | 6.92% | 11.99% | Upgrade
|
| Return on Invested Capital (ROIC) | 0.30% | 0.85% | 4.00% | 5.46% | 13.19% | 21.52% | Upgrade
|
| Return on Capital Employed (ROCE) | 0.30% | 0.80% | 3.90% | 4.70% | 11.50% | 23.60% | Upgrade
|
| Earnings Yield | -1.86% | -0.53% | 1.58% | 3.39% | 6.68% | 5.89% | Upgrade
|
| FCF Yield | -4.89% | -2.17% | -4.11% | 0.26% | -1.36% | 6.25% | Upgrade
|
| Dividend Yield | 1.00% | - | 0.80% | 1.04% | 2.11% | 1.73% | Upgrade
|
| Payout Ratio | - | - | 90.84% | 78.26% | 44.97% | 31.00% | Upgrade
|
| Buyback Yield / Dilution | 0.36% | 1.38% | -0.01% | -0.77% | -9.16% | 0.11% | Upgrade
|
| Total Shareholder Return | 1.36% | 1.38% | 0.78% | 0.28% | -7.05% | 1.83% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.